↓ Skip to main content

Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie

Overview of attention for article published in Der Nervenarzt, February 2016
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Monitoring von Blutparametern unter verlaufsmodifizierender MS-Therapie
Published in
Der Nervenarzt, February 2016
DOI 10.1007/s00115-016-0077-1
Pubmed ID
Authors

L. Klotz, A. Berthele, W. Brück, A. Chan, P. Flachenecker, R. Gold, A. Haghikia, K. Hellwig, B. Hemmer, R. Hohlfeld, T. Korn, T. Kümpfel, M. Lang, V. Limmroth, R. A. Linker, U. Meier, S. G. Meuth, F. Paul, A. Salmen, M. Stangel, B. Tackenberg, H. Tumani, C. Warnke, M. S. Weber, T. Ziemssen, F. Zipp, H. Wiendl

Abstract

With the approval of various substances for the immunotherapy of multiple sclerosis (MS), treatment possibilities have improved significantly over the last few years. Indeed, the choice of individually tailored preparations and treatment monitoring for the treating doctor is becoming increasingly more complex. This is particularly applicable for monitoring for a treatment-induced compromise of the immune system. The following article by members of the German Multiple Sclerosis Skills Network (KKNMS) and the task force "Provision Structures and Therapeutics" summarizes the practical recommendations for approved immunotherapy for mild to moderate and for (highly) active courses of MS. The focus is on elucidating the substance-specific relevance of particular laboratory parameters with regard to the mechanism of action and the side effects profile. To enable appropriate action to be taken in clinical practice, any blood work changes that can be expected, in addition to any undesirable laboratory findings and their causes and relevance, should be elucidated.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 5 16%
Professor 5 16%
Other 4 13%
Student > Doctoral Student 2 6%
Student > Bachelor 2 6%
Other 6 19%
Unknown 8 25%
Readers by discipline Count As %
Neuroscience 6 19%
Medicine and Dentistry 6 19%
Unspecified 5 16%
Biochemistry, Genetics and Molecular Biology 3 9%
Immunology and Microbiology 2 6%
Other 1 3%
Unknown 9 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2016.
All research outputs
#21,141,111
of 23,794,258 outputs
Outputs from Der Nervenarzt
#771
of 905 outputs
Outputs of similar age
#253,541
of 299,285 outputs
Outputs of similar age from Der Nervenarzt
#16
of 18 outputs
Altmetric has tracked 23,794,258 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 905 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 299,285 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.